XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 12,523 $ 4,673 $ 35,125 $ 7,415
General and administrative 5,239 3,195 14,609 3,982
Total operating expenses 17,762 7,868 49,734 11,397
Loss from operations (17,762) (7,868) (49,734) (11,397)
Other income (expense):        
Interest income 105 23 333 59
Interest expense       (653)
Other income (expense) (56) 1 (57) 1
Total other income (expense), net 49 24 276 (593)
Net loss (17,713) (7,844) (49,458) (11,990)
Repurchase and retirement of Series A and Series A-1 convertible preferred stock   (1,869)   (1,869)
Net loss attributable to common stockholders $ (17,713) $ (9,713) $ (49,458) $ (13,859)
Net loss per share, basic $ (0.45) $ (3.71) $ (1.25) $ (5.29)
Net loss per share, diluted $ (0.45) $ (3.71) $ (1.25) $ (5.29)
Weighted average shares used to compute net loss per share, basic 39,607,745 2,617,543 39,450,655 2,617,543
Weighted average shares used to compute net loss per share, diluted 39,607,745 2,617,543 39,450,655 2,617,543